missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human Dendritic Cell Enrichment Cocktail, BD
For selecton of negative dendritic cells from peripheral blood
Brand: BD Biosciences 558420
Alert:
Avoid exposure to skin and eyes, ingestion, and contact with heat, acids, and metals
Includes:
- Human Dendritic Cell Enrichment Cocktail, 5.0 ml:
- Biotin Mouse Anti-human CD3, clone UCHT1
- Biotin Mouse Anti-human CD14, clone M5E2
- Biotin Mouse Anti-human CD19, clone HIB19
- Biotin Mouse Anti-human CD41a, clone HIP8
- Biotin Mouse Anti-human CD56, clone B159
- Biotin Mouse Anti-human CD66b, clone G10F5
- Biotin Mouse Anti-human CD235a (Glycophorin A), clone GA-R2 (HIR2)
- Biotin Mouse Anti-human IgE, clone G7-26
- in Aqueous buffered solution containing 0.09% Sodium Azide
- BD IMag Streptavidin Particles Plus - DM, 7.5 ml:
- in Aqueous buffered solution containing BSA™ and 0.09% Sodium Azide
Description
Simultaneously stains erythrocytes, platelets, and most leukocytes except the DC. Negative selection is then performed to enrich for the unlabeled DC
- Contains biotinylated monoclonal antibodies that recognize antigens expressed on erythrocytes, platelets, and peripheral leukocytes that are not DC
- BD IMag™ Streptavidin Particles Plus – DM are magnetic nanoparticles that have streptavidin covalently conjugated to their surfaces
- Avoids the inadvertent activation of enriched DC by using reagents that do not directly bind to DC
Applications:
Flow cytometry, Tissue culture
Specifications
4°C | |
5mL | |
Dendritic Cell Enrichment Cocktail |
Human Dendritic Cell enrichment cocktail, 5mL: Biotin Mouse Anti-Human CD3, clone UCHT1, CD14, clone M5E2, CD19, clone HIB19, CD41a, clone HIP8, CD56, clone B159, CD66b, clone G10F5, CD235a (Glycophorin A), clone GA-R2 (HIR2), IgE, clone G7-26, BD IMag Streptavidin particles Plus - DM, 7.5mL | |
RUO |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Research use only
Spot an opportunity for improvement?Share a Content Correction